Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Antimicrobial hygromycin A derivatives in development at Pfizer

July 21, 2000

Complete inhibition of HCMV replication obtained on combination regimens

July 21, 2000

Alcon to develop drop formulation of moxifloxacin

July 21, 2000

Inhibitors of fungal chitin synthase a focus of research at Roche

July 20, 2000

NewBiotics' NB-2001 may eliminate resistant bacteria

July 19, 2000

Abbott's novel antifungal lipopeptide characterized in vitro

July 19, 2000

FDA approves Malarone for prevention and treatment of malaria

July 18, 2000

Agouron's HRV 3C protease inhibitor shows positive in vitro results

July 18, 2000

Potent, broad-spectrum carbapenems in development at Sankyo

July 17, 2000

Microbially produced macrolide antifungal agent discovered in Spain

July 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...